2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023

2019 ASCCP Risk-Based Management Consensus Guidelines Committee

doi:10.1097/lgt.0000000000000788

2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023

2019 ASCCP Risk-Based Management Consensus Guidelines Committee

Obstetrics, Gynecology and Women's Health - Oncology

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

This Research Letter summarizes all updates to the 2019 Guidelines through September 2023, including: endorsement of the 2021 Opportunistic Infections guidelines for HIV+ or immunosuppressed patients; clarification of use of human papillomavirus testing alone for patients undergoing observation for cervical intraepithelial neoplasia 2; revision of unsatisfactory cytology management; clarification that 2012 guidelines should be followed for patients aged 25 years and older screened with cytology only; management of patients for whom colposcopy was recommended but not completed; clarification that after treatment for cervical intraepithelial neoplasia 2+, 3 negative human papillomavirus tests or cotests at 6, 18, and 30 months are recommended before the patient can return to a 3-year testing interval; and clarification of postcolposcopy management of minimally abnormal results.

Original language	English (US)
Pages (from-to)	3-6
Number of pages	4
Journal	Journal of lower genital tract disease
Volume	28
Issue number	1
DOIs	https://doi.org/10.1097/lgt.0000000000000788
State	Published - Jan 1 2024

Bibliographical note

Publisher Copyright:
© 2023 Lippincott Williams & Wilkins.

Keywords

2019 ASCCP guidelines
cervical cancer screening and management
updates

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1097/lgt.0000000000000788License: CC BY-NC-ND

Find It

Find It at U of M Libraries

Cite this

@article{20a7ef4b93634ad69f19d99b87f7b3a3,

title = "2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023",

abstract = "This Research Letter summarizes all updates to the 2019 Guidelines through September 2023, including: endorsement of the 2021 Opportunistic Infections guidelines for HIV+ or immunosuppressed patients; clarification of use of human papillomavirus testing alone for patients undergoing observation for cervical intraepithelial neoplasia 2; revision of unsatisfactory cytology management; clarification that 2012 guidelines should be followed for patients aged 25 years and older screened with cytology only; management of patients for whom colposcopy was recommended but not completed; clarification that after treatment for cervical intraepithelial neoplasia 2+, 3 negative human papillomavirus tests or cotests at 6, 18, and 30 months are recommended before the patient can return to a 3-year testing interval; and clarification of postcolposcopy management of minimally abnormal results.",

keywords = "2019 ASCCP guidelines, cervical cancer screening and management, updates",

author = "\{2019 ASCCP Risk-Based Management Consensus Guidelines Committee\} and Perkins, \{Rebecca B.\} and Guido, \{Richard S.\} and Castle, \{Philip E.\} and David Chelmow and Einstein, \{Mark H.\} and Francisco Garcia and Huh, \{Warner K.\} and Kim, \{Jane J.\} and Moscicki, \{Anna Barbara\} and Ritu Nayar and Mona Saraiya and Sawaya, \{George F.\} and Nicolas Wentzensen and Mark Schiffman and Deborah Arrindell and Pelin Batur and Alicia Carter and Patty Cason and Xiaojian Chen and Li Cheung and Kim Choma and Megan Clarke and Christine Conageski and Miriam Cremer and Barbara Crothers and Teresa Darragh and Maria Demarco and Eileen Duffey-Lind and Ysabel Duron and Didem Egemen and Carol Eisenhut and Tamika Felder and Sarah Feldman and Michael Gold and Robert Goulart and Paul Han and Sally Hersh and Aimee Holland and Eric Huang and Michelle Khan and Rachel Kupets and Margaret Long and Thomas Lorey and Jennifer Loukissas and Jeanne Murphy and Amber Naresh and Erin Nelson and Akiva Novetsky and Jeffrey Quinlan and Deanna Teoh",

note = "Publisher Copyright: {\textcopyright} 2023 Lippincott Williams \& Wilkins.",

year = "2024",

month = jan,

day = "1",

doi = "10.1097/lgt.0000000000000788",

language = "English (US)",

volume = "28",

pages = "3--6",

journal = "Journal of lower genital tract disease",

issn = "1089-2591",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - 2019 ASCCP Risk-Based Management Consensus Guidelines

T2 - Updates Through 2023

AU - 2019 ASCCP Risk-Based Management Consensus Guidelines Committee

AU - Perkins, Rebecca B.

AU - Guido, Richard S.

AU - Castle, Philip E.

AU - Chelmow, David

AU - Einstein, Mark H.

AU - Garcia, Francisco

AU - Huh, Warner K.

AU - Kim, Jane J.

AU - Moscicki, Anna Barbara

AU - Nayar, Ritu

AU - Saraiya, Mona

AU - Sawaya, George F.

AU - Wentzensen, Nicolas

AU - Schiffman, Mark

AU - Arrindell, Deborah

AU - Batur, Pelin

AU - Carter, Alicia

AU - Cason, Patty

AU - Chen, Xiaojian

AU - Cheung, Li

AU - Choma, Kim

AU - Clarke, Megan

AU - Conageski, Christine

AU - Cremer, Miriam

AU - Crothers, Barbara

AU - Darragh, Teresa

AU - Demarco, Maria

AU - Duffey-Lind, Eileen

AU - Duron, Ysabel

AU - Egemen, Didem

AU - Eisenhut, Carol

AU - Felder, Tamika

AU - Feldman, Sarah

AU - Gold, Michael

AU - Goulart, Robert

AU - Han, Paul

AU - Hersh, Sally

AU - Holland, Aimee

AU - Huang, Eric

AU - Khan, Michelle

AU - Kupets, Rachel

AU - Long, Margaret

AU - Lorey, Thomas

AU - Loukissas, Jennifer

AU - Murphy, Jeanne

AU - Naresh, Amber

AU - Nelson, Erin

AU - Novetsky, Akiva

AU - Quinlan, Jeffrey

AU - Teoh, Deanna

PY - 2024/1/1

Y1 - 2024/1/1

N2 - This Research Letter summarizes all updates to the 2019 Guidelines through September 2023, including: endorsement of the 2021 Opportunistic Infections guidelines for HIV+ or immunosuppressed patients; clarification of use of human papillomavirus testing alone for patients undergoing observation for cervical intraepithelial neoplasia 2; revision of unsatisfactory cytology management; clarification that 2012 guidelines should be followed for patients aged 25 years and older screened with cytology only; management of patients for whom colposcopy was recommended but not completed; clarification that after treatment for cervical intraepithelial neoplasia 2+, 3 negative human papillomavirus tests or cotests at 6, 18, and 30 months are recommended before the patient can return to a 3-year testing interval; and clarification of postcolposcopy management of minimally abnormal results.

AB - This Research Letter summarizes all updates to the 2019 Guidelines through September 2023, including: endorsement of the 2021 Opportunistic Infections guidelines for HIV+ or immunosuppressed patients; clarification of use of human papillomavirus testing alone for patients undergoing observation for cervical intraepithelial neoplasia 2; revision of unsatisfactory cytology management; clarification that 2012 guidelines should be followed for patients aged 25 years and older screened with cytology only; management of patients for whom colposcopy was recommended but not completed; clarification that after treatment for cervical intraepithelial neoplasia 2+, 3 negative human papillomavirus tests or cotests at 6, 18, and 30 months are recommended before the patient can return to a 3-year testing interval; and clarification of postcolposcopy management of minimally abnormal results.

KW - 2019 ASCCP guidelines

KW - cervical cancer screening and management

KW - updates

UR - http://www.scopus.com/inward/record.url?scp=85180420590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85180420590&partnerID=8YFLogxK

U2 - 10.1097/lgt.0000000000000788

DO - 10.1097/lgt.0000000000000788

M3 - Article

C2 - 38117563

AN - SCOPUS:85180420590

SN - 1089-2591

VL - 28

SP - 3

EP - 6

JO - Journal of lower genital tract disease

JF - Journal of lower genital tract disease

IS - 1

ER -

2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this